Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
NTRBW
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
globenewswire.com
6 hours ago
globenewswire.com
8 hours ago
globenewswire.com
16 hours ago
zacks.com
19 hours ago
Earnings Growth
YoY
Current
Estimates
Q4.23
N/A
-0.22
vs -0.14
Q1.24
N/A
NA
vs -0.20
Q2.24
N/A
NA
vs -0.13
Q3.24
N/A
NA
vs -0.11
Q4.24
N/A
NA
vs -0.22
Q1.25
N/A
NA
vs NA
Q2.25
N/A
-0.12
vs NA
Q3.25
N/A
-0.18
vs NA
Q4.25
N/A
-2.13
vs NA
Q1.26
N/A
-1.89
vs NA
Sales Growth
YoY
Current
Estimates
Q4.23
-31%
427.8K vs 618K
Q1.24
-1%
524.6K vs 527.5K
Q2.24
-14%
408.5K vs 476.9K
Q3.24
-32%
442.8K vs 655.9K
Q4.24
+51%
645.8K vs 427.8K
Q1.25
+22%
642.4K vs 524.6K
Q2.25
+63%
667.4K vs 408.5K
Q3.25
+41%
622.5K vs 442.8K
Q4.25
+5%
675K vs 645.8K
Q1.26
+19%
765K vs 642.4K
Return on Equity
QoQ
Q2.23
-13%
-0.13
vs -0.20
Q3.23
-12%
-0.12
vs -0.13
Q4.23
-31%
-0.31
vs -0.12
Q1.24
-29%
-0.29
vs -0.31
Q2.24
-14%
-0.14
vs -0.29
Q3.24
-14%
-0.14
vs -0.14
Q4.24
-12%
-0.12
vs -0.14
Q1.25
-86%
-0.86
vs -0.12
Q2.25
-27%
-0.27
vs -0.86
Q3.25
-24%
-0.24
vs -0.27
Institutionnal Ownership
QoQ
Q1.23
2
2
vs 1
100%
Q2.23
3
3
vs 2
50%
Q3.23
3
3
vs 3
NA
Q4.23
2
2
vs 3
-33%
Q1.24
4
4
vs 2
100%
Q2.24
4
4
vs 4
NA
Q3.24
4
4
vs 4
NA
Q4.24
4
4
vs 4
NA
Q1.25
3
3
vs 4
-25%
Q2.25
3
3
vs 3
NA
Forecast
339%2026-Revenue
-192%2026-EPS
-40%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
N/A(N/A)
Number of analyst
N/A
Last analyst upgrade/downgrade
No Data Available
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated in 2016 and is headquartered in Orlando, Florida.
NASDAQ
Unprofitable
Unprofitable
Relative Strenght
6
Volume Buzz
-85%
Earning Acce
No
Dist 52w H.
53%Quote Panel
Key Metrics
Relative Strength
NTRBW
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|